Heidelberg, 22nd January 2016
German Cancer Research Center (DKFZ) Heidelberg
In the light of exciting new molecular insight in lymphoma biology which rapidly transforms current treatment approaches, the one day meeting will summarize our current understanding of pathogenesis, sum up current standard treatments and discuss future developments in indolent lymphoma, CLL, aggressive B- and T cell lymphoma.